Although the VCAM1–ApoE axis is important for IL-33-stimulated microglial chemotaxis toward Aβ plaques and subsequent Aβ clearance, it is unclear if patients with AD have impaired microglial VCAM1 signaling. This evidence concerns the gene VCAM1 and Alzheimer disease.